Joseph Gricar
Overview
Explore the profile of Joseph Gricar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
772
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaffe D, Gricar J, DeCongelio M, Mackie D
Thorac Cancer
. 2022 Mar;
13(9):1240-1257.
PMID: 35355433
Background: Esophageal cancer is a highly prevalent cancer associated with low survival, especially among those with advanced disease. Second-line (2L) treatment patterns and related clinical outcomes of patients with advanced...
2.
Doki Y, Ajani J, Kato K, Xu J, Wyrwicz L, Motoyama S, et al.
N Engl J Med
. 2022 Feb;
386(5):449-462.
PMID: 35108470
Background: First-line chemotherapy for advanced esophageal squamous-cell carcinoma results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival benefit over chemotherapy in previously treated patients with advanced...
3.
Danese M, Gricar J, Abraham P
Future Oncol
. 2022 Jan;
18(8):927-936.
PMID: 35081734
To characterize real-world patterns of second-line treatment and outcomes in older patients with advanced/metastatic esophageal squamous cell carcinoma (ESCC). Patients aged ≥66 years diagnosed with advanced/metastatic ESCC between 2010 and...
4.
Lenz H, Van Cutsem E, Limon M, Wong K, Hendlisz A, Aglietta M, et al.
J Clin Oncol
. 2021 Oct;
40(2):161-170.
PMID: 34637336
Purpose: Nivolumab received US Food and Drug Administration approval as a single agent or in combination with ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC) that...
5.
Abraham P, Wang L, Jiang Z, Gricar J, Tan H, Kelly R
Future Oncol
. 2020 Sep;
17(3):291-299.
PMID: 32996811
Study first-line (1L) treatment patterns and economic outcomes among patients with advanced metastatic gastric cancer (GC) and esophageal cancer (EC). Newly diagnosed patients with systemic GC and EC treatments were...
6.
Hawkins K, Mittapally R, Chang J, Nahum G, Gricar J
Curr Med Res Opin
. 2010 Nov;
26(12):2823-32.
PMID: 21058896
Objective: To estimate the burden of illness (BOI) of hypertension in a cohort of women receiving menopausal hormone therapy (HT). Methods: Patients with at least one prescription for menopausal HT...
7.
Rendas-Baum R, Yang M, Gricar J, Wallenstein G
Appl Health Econ Health Policy
. 2010 Feb;
8(2):129-40.
PMID: 20175591
Background: Premenstrual syndrome (PMS) is reported to affect between 13% and 31% of women. Between 3% and 8% of women are reported to meet criteria for the more severe form...
8.
Trussell J, Lalla A, Doan Q, Reyes E, Pinto L, Gricar J
Contraception
. 2008 Dec;
79(1):5-14.
PMID: 19041435
Background: The study was conducted to estimate the relative cost effectiveness of contraceptives in the United States from a payer's perspective. Methods: A Markov model was constructed to simulate costs...
9.
Doyle J, Stern L, Hagan M, Hao J, Gricar J
J Womens Health (Larchmt)
. 2008 Aug;
17(6):987-92.
PMID: 18681819
Contraceptive use in the United States is virtually universal among women of reproductive age. However, unplanned pregnancies continue to occur and can be largely attributed to the nonuse and misuse...
10.
Gricar J, Deutsch S, Blackburn J, Zyczynski T
Radiol Manage
. 2007 Nov;
29(5):34-8.
PMID: 17983038
Injuries and the resultant costs of injuries in today's healthcare environment are driving the need for healthcare to adopt measures to improve workplace safety for employees and increase safety for...